Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Postmenopausal: early-phase trial registry
2 of 10 indexed Postmenopausal trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,724 of 28,707 conditions by registered trial count.
10 US clinical trials · 2 currently recruiting · #1,724 of 28,707 conditions by registered trial count
Postmenopausal: 10 US clinical trials tracked, 2 recruiting.
Postmenopausal is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Warner Chilcott, running 1 of these trials.
Enrollment posture brief
Registry condition postmenopausal
OPEN 2 | RECR 20% | LATE 0 | EARLY 4 | RANK #1724 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acral Lentiginous Melanoma (20% recruiting · 5 trials)
Postmenopausal lists 2 open slots (20% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Postmenopausal on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Postmenopausal is recruiting below its size-band peers.
2 of 10 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Postmenopausal trials is spread across many organizations.
Warner Chilcott accounts for 1 of 10 trials (10%). 10 distinct sponsors appear on at least one study for this condition label.
-
Most Postmenopausal trials plan to enrol fewer than 100 people.
Median target enrolment is 72 among the 10 trials that report a genuine target (sentinel values excluded). 7 of those (70%) plan for fewer than 100 participants.
-
Postmenopausal research is mostly interventional.
10 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
10 total, page 1 of 1
Protein and Exercise for Postmenopausal Women's Wellbeing
University of Arkansas, Fayetteville
NCT06849817
Short-term Circuit Training on Muscle Mass and Quality of Life in Sedentary Postmenopausal Women
Loma Linda University
NCT06445842
Safety, Pharmacokinetics, and Efficacy of 100, 150, and 200 mg Risedronate Administered to Women With Low BMD
Warner Chilcott
NCT00577837
A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy
Janssen Research & Development
NCT01381874
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
NRG Oncology
NCT03180294
Impact of Weight Loss Interventions for Overweight Breast Cancer Survivors
University of Vermont
NCT01482702
Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors
City of Hope Medical Center
NCT02235051
Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer
University of Michigan Rogel Cancer Center
NCT06228768
Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients
M.D. Anderson Cancer Center
NCT02152943
Weight Bearing Exercise in Preventing Frailty in Stage I-IIIA Breast Cancer Survivors
University of Arizona
NCT03708055
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Postmenopausal records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Postmenopausal trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Postmenopausal page
10 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Postmenopausal trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Warner Chilcott sponsors the most Postmenopausal trials on record, review their full trial history before evaluating a specific study. See Warner Chilcott's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Postmenopausal condition card totals 10 registered trials; most-linked intervention experimental; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.